Manning & Napier Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.9M Sell
125,749
-3,457
-3% -$718K 0.38% 54
2026
Q1
$27.3M Buy
129,206
+129,196
+1,291,960% +$27.8M 0.38% 56
2025
Q4
$2.07K Buy
+10
New +$1.88K ﹤0.01% 488
2017
Q3
$4.25M Sell
63,515
-5,368
-8% -$379K 0.04% 200
2017
Q2
$5.37M Buy
+68,883
New +$5.2M 0.05% 176
2014
Q2
Sell
-18,931
Closed -$1.32M 370
2014
Q1
$1.32M Sell
18,931
-546
-3% -$38K 0.01% 308
2013
Q4
$1.3M Sell
19,477
-11,292
-37% -$690K 0.01% 297
2013
Q3
$1.6M Buy
30,769
+418
+1% +$21.2K 0.01% 289
2013
Q2
$1.43M Buy
+30,351
New +$1.39M 0.01% 283

Other funds holding CAH

Manning & Napier Advisors's CAH Position: Q2 2026 in Review

Manning & Napier Advisors reduced its Cardinal Health (CAH) stake by 2.7% in Q2 2026, selling an estimated $718K and leaving 125,749 shares worth $29.9M. The position accounts for 0.38% of the portfolio, ranked #54.

Manning & Napier Advisors first reported a position in CAH in Q2 2013 and has held it in 9 quarters since. 1,497 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Manning & Napier Advisors held 125,749 shares of Cardinal Health worth $29.9M as of Q2 2026.
  • Manning & Napier Advisors sold 3,457 Cardinal Health shares in Q2 2026, an estimated $718K.
  • Cardinal Health made up 0.38% of Manning & Napier Advisors's portfolio in Q2 2026, its #54 holding.
  • Manning & Napier Advisors first reported a position in Cardinal Health in Q2 2013 and has held it in 9 quarters since.
  • 1,497 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.